Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, May 1998, p. 1012-1014, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Field Evaluation of the Prophylactic Effect of an
Isometamidium Sustained-Release Device against Trypanosomiasis in
Cattle
B.
Diarra,1
O.
Diall,1
S.
Geerts,2,*
P.
Kageruka,2
Y.
Lemmouchi,3
E.
Schacht,3
M. C.
Eisler,4 and
P.
Holmes4
Laboratoire Central Vétérinaire,
Bamako, Mali1;
Institute of Tropical
Medicine, 2000 Antwerp,2 and
Laboratory of Polymers, University of Ghent, 9000 Ghent,3 Belgium; and
Veterinary
School, University of Glasgow, Glasgow G61 1QH, United
Kingdom4
Received 18 July 1997/Returned for modification 9 September
1997/Accepted 19 February 1998
 |
ABSTRACT |
In order to compare the prophylactic effect provided by a
poly(D,L-lactide) sustained-release device
(SRD) containing isometamidium (ISMM) with that provided by the
classical intramuscular injection of the drug, a field trial was
carried out at the Madina Diassa Ranch in Mali. One- to 3-year-old
N'Dama cattle were randomly divided into three groups. The first group
(n = 42) was treated with ISMM at a dose of 1 mg/kg of
body weight, the second group (n = 44) received the
same dose of the drug via an SRD, which was subcutaneously implanted in
the shoulder region, and the third group (n = 36) was
kept as an untreated control group. All animals were treated with
diminazene aceturate (7 mg/kg of body weight) 2 weeks before the start
of the experiment and were tested monthly by the buffy coat technique
for a period of 8 months. Glossina morsitans submorsitans
was the most important tsetse species, with apparent densities (number
of catches/trap/day) varying between 11.9 and 38.7 over the
experimental period. Eight months after treatment the cumulative
infection rates were 27.7, 58.5, and 77.4% in the group with the SRD
implant, the group receiving the intramuscular injection, and the
control group, respectively. Statistical analysis showed that the
incidence of trypanosomiasis was significantly lower
(P = 0.006) in the group which received ISMM via the
SRD than in the one which was treated with ISMM intramuscularly.
 |
INTRODUCTION |
The number of drugs currently
available for prophylaxis of bovine trypanosomiasis in Africa is
limited. Isometamidium chloride (ISMM) and homidium, which are widely
used, have narrow therapeutic indices and considerable variation in
their prophylactic activities has been observed (16, 18). In
order to extend the period of protection provided by these drugs and to
decrease their local toxicities, different alternative delivery
systems, such as suraminates, dextran complexes, liposomal
formulations, carrier erythrocytes, and polymers, have been developed
(16). Except for the polymers, very few of these
formulations have been successful.
After some successful preliminary experiments with rabbits (6, 11,
13), Geerts et al. (12) reported that the prophylactic activities of ISMM and homidium in cattle could be extended
significantly by incorporating the drugs in polymers in order to
produce sustained-release devices (SRDs). Using a
poly(D,L-lactide) SRD, an extension of the
protection period of ISMM by a factor of 3.2 was obtained. This
experiment was carried out under experimental conditions by exposing
cattle to tsetse flies infected with drug-sensitive Trypanosoma
congolense (clone IL 1180). The present experiment was undertaken
in order to evaluate the efficacy of
poly(D,L-lactide) SRDs containing ISMM in
protecting cattle maintained under conditions of heavy tsetse fly
challenge at the Madina Diassa Ranch in Mali. Regular prophylactic
treatment of the N'Dama cattle at this ranch is necessary in order to
avoid mortality due to trypanosomiasis (7, 8).
 |
MATERIALS AND METHODS |
SRDs.
Biodegradable SRDs were prepared by extrusion of a
mixture of poly(D,L-lactide) and ISMM
(Trypamidium; Rhône-Mérieux). The SRDs consisted of
cylindrical rods that were 3 mm in diameter and about 3 cm in length
and that were loaded with 25% (wt/wt) ISMM. They were coated by
dipping them in a poly(D,L-lactide)-chloroform solution (10% [wt/vol]). Dexamethasone (1% [wt/wt]) was added to
the coating of the SRDs to reduce the tissue reaction at the implantation site.
Experimental site.
The experiment was carried out at the
Madina Diassa Ranch, about 300 km south of Bamako, Mali. The climate is
tropical and semihumid and is of the soudano-guinean type, with a wet
season of about 6 months (May to October) and a dry season from
November to April. The N'Dama cattle were kept in herds, which had
access to the pasture during the hours of daylight (between 0800 and 1700 h). At night they were kept inside a kraal. Cotton grains, vitamins, and minerals were given as a feed supplements. The animals were vaccinated against the most important diseases, such as
rinderpest, contagious pleuropneumonia, anthrax, blackleg, and
pasteurellosis. Acaricidal treatment was given once a month during the
dry season and twice monthly during the wet season. No tsetse control
operations had been carried out at the ranch since 1983.
Two herds of 1- to 3-year-old N'Dama cattle, consisting of 65 female
and 57 male animals, respectively, were included in the experiment.
Each of the two herds was randomly divided into three groups, two of
which received ISMM either via an SRD or intramuscularly (i.m.). The
third group served as a control group. The male and the female herds
grazed separately, but in close proximity. Within each herd all groups
of animals grazed together. Hence, all cattle were exposed to similar
tsetse challenges.
Experimental protocol.
The study began in November 1995. Two
weeks before the start of the experiment all animals were treated with
7 mg of diminazene aceturate (Berenil; 7% aqueous solution; Hoechst)
per kg of body weight in order to clear all trypanosome infections. The
first group (21 males and 21 females) was treated by i.m. injection of
ISMM (Trypamidium; 2% [wt/vol] aqueous solution; Rhône
Mérieux) at a dose of 1 mg/kg of body weight. The second group
(22 males and 22 females) received the same dose of the drug via a
subcutaneously implanted SRD. The SRDs were administered in the
shoulder region with an implanter (Crestar; Intervet). Each animal
received two to three rods, according to the animal's body weight. The
third group (14 males and 22 females) consisted of untreated control animals. At the start of the trial the average weight of the three groups of cattle varied between 117 and 125 kg.
Parasitological examination was carried out by the dark-background
buffy coat technique (14) 2 weeks prior to treatment and
every month until 8 months posttreatment. Simultaneously, thin blood
smears were prepared; these were then stained with Giemsa stain and
were examined to identify the trypanosome species. Any animal which
became parasitemic during the trial was immediately treated with
diminazene aceturate at 7 mg/kg of body weight.
Tsetse fly challenge.
The apparent density of the tsetse
flies at the site of the trial was measured before the start of the
experiment and, beginning 1 month after treatment, at 2-month intervals
during the experiment. Ten biconical traps (4) were used at
the grazing site (savannah) and 10 were used at the watering site
(forest gallery). They were placed at intervals of about 100 to
200 m. The flies were collected after 24 and 48 h. The
apparent density was calculated as the mean number of flies per trap
per day. A total of 257 Glossina morsitans submorsitans
flies obtained at 3, 5, and 7 months after the start of the experiment
were examined. The proboscis, intestine, and salivary glands were
dissected as described by Pollock (19) in order to determine
the degree of infection and to identify the trypanosome species.
Drug sensitivities of trypanosomes.
In order to examine the
drug sensitivities of the trypanosomes circulating at the ranch, nine
stocks of trypanosomes (four Trypanosoma vivax stocks and
five Trypanosoma congolense stocks) were isolated from local
cattle 2 months before the start of the experiment; the isolates were
either cryopreserved in liquid nitrogen or blood from infected animals
was inoculated into mice. Two pools were prepared by using two and
three T. congolense stocks, respectively. Another pool
contained all four T. vivax stocks. Each pool was inoculated
into three young bovines (Zebu and Zebu crosses) originating from a
tsetse fly-free area in Mali (Sotuba). These animals were kept in a
stable during the course of the experiment and were treated with
deltamethrin (Butox) pour-on at 2-week intervals. Once the animals
became parasitemic, two of them were treated with ISMM at 0.5 mg/kg of
body weight and one was treated with diminazene aceturate at 3.5 mg/kg
of body weight. These doses were chosen because they are the lowest
doses which are efficacious against both trypanosome species for
prophylactic and curative purposes, respectively. Buffy coat
examination of the blood (14) was carried out three times a
week for a period of 100 days posttreatment.
Statistical analysis.
The incidence of trypanosomiasis in
the three groups of N'Dama cattle in the field was compared by the
method of survival analysis (5). The Cox-Mantel Two-Sample
test was used to compare the two treatment methods.
 |
RESULTS AND DISCUSSION |
Parasitological results.
The parasitological results for
cattle exposed to natural tsetse fly challenge at the Madina Diassa
Ranch are presented in Fig. 1. Eight
months after treatment the cumulative rates of infection were 27.7, 58.5, and 77.4% for the cattle with implants, the i.m. treated cattle,
and the control group, respectively. Survival analysis showed a highly
significant difference between treated and nontreated animals over the
whole of the experimental period (P < 0.001). The
risks of infection (hazard rate) for the group with the implants and
the i.m. treated group compared to that for the control group were 0.24 and 0.54, respectively. The Cox-Mantel Two-Sample test showed a
significant difference in the incidence of trypanosomiasis between the
two treatment groups (C = 2.504; P = 0.006). These data confirm the results of Geerts et al.
(12), who showed that under experimental conditions a
significant extension of the protection period of ISMM could be
obtained with poly(D,L-lactide) SRDs. It is
noteworthy that during the first 3 months after treatment none of the
animals in the group treated i.m. became positive, whereas 3 of 44 (6.8%) cattle which received the SRD became infected. These 3 animals
were all infected with T. vivax, unlike the 15 animals in
the control group with infections which occurred over the same period,
of which 6 were infected with T. vivax and 9 were infected
with T. congolense. Previous experiments with the same type
of SRD under controlled conditions have shown that the peak
concentrations of ISMM in serum (0.8 ng/ml) were reached only 3 to 4 weeks after implantation (12). It is possible, therefore, that in some animals the level of the drug during the first weeks after
the implantation might have been insufficient to prevent T. vivax infections. Several investigators (10, 15, 17, 21) have already suggested that ISMM might be less effective against T. vivax than against T. congolense.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Cumulative trypanosome infection rate in two treatment
groups which received ISMM either via an implanted SRD ( ) or as an
i.m. injection (+) compared to that in the control group (*).
|
|
Tsetse fly challenge.
The apparent densities of the different
species of tsetse flies at the ranch are presented in Fig.
2. It shows that G. morsitans submorsitans was the most important species, which confirms
earlier observations (9). During the course of the
experiment the proportion of G. morsitans submorsitans flies
infected with trypanosomes varied between 22.4 and 24.4%, of which 46 to 68% harbored metacyclic trypanosomes. T. vivax was the
most common parasite and was found in 61.2% of the infected flies
examined, followed by T. congolense (14.9%) and
Trypanosoma brucei (1.8%). Trypanosoma grayi was
identified in 1.5% of the flies, and 20.6% were immature infections.
These data suggest that the cattle at the site of the experiment were exposed to a high level of tsetse fly challenge.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Apparent densities (AD) of G. morsitans
submorsitans (at pasture) ( ) and of Glossina palpalis
gambiensis ( ) and Glossina tachinoides ( ) (both
at cattle watering sites) at the Madina Diassa Ranch.
|
|
Drug sensitivity of local trypanosome populations.
No
breakthrough infections were observed for a period of 100 days after
ISMM or diminazene aceturate treatment of the animals inoculated with
the pools of T. congolense or T. vivax. Since it
has been possible for investigators to identify resistant trypanosome isolates by a similar approach in Somalia (1) and since no problems of resistance to trypanocidal drugs were reported at the ranch
during the previous years, resistant trypanosome strains are probably
not present at the ranch.
Other parameters.
Although the SRDs were coated with
dexamethasone (1% [wt/wt]), some swelling was observed at the
implantation site in most of the animals. The dimensions of these
nodules varied from 1 to 3 cm in diameter, and the nodules decreased in
size during the course of the experiment. In most of the animals the
nodules had disappeared by 8 months posttreatment. In contrast to the necrotic lesions observed after i.m. injection of ISMM (3), these tissue reactions were subcutaneous and therefore unlikely to
affect the quality of the carcass.
From the results of this experiment it can be concluded that the use of
poly(
D,
L-lactide) SRDs allows the period of
prophylaxis
afforded by ISMM to be extended significantly, even under
conditions
of heavy tsetse fly challenge in a field situation. Further
potential
advantages of these devices over the classical i.m. use of
the
drug are as follows: (i) there is less of a possibility of diluting
the product or underdosing the animal, (ii) there is no requirement
for
sterile water, (iii) there are no potentially toxic residues
at the
injection sites in the muscles, and (iv) veterinary services
are easier
to control since SRDs can be administered only with
special implanters,
which are not widely available to farmers.
In order to avoid the
breakthrough infections immediately after
the implantation of the SRD,
the devices could be modified to
improve the release rate during the
first weeks after implantation.
This could be achieved by improving the
permeability of the polymer
matrix either by copolymerization with
another suitable comonomer
or by the addition of a plasticizer, e.g.,
low-molecular-weight
poly(
D,
L-lactide).
Alternatively, combining the administration
of the SRDs with a sanative
treatment with diminazene aceturate
might also reduce the number of
early breakthrough infections.
Possible toxic reactions due to this
drug combination should be
carefully evaluated, but none is anticipated
because the high
peak concentrations of ISMM immediately after the i.m.
injection,
which are mainly responsible for acute toxicity, are absent
when
SRDs are used (
12). Moreover, the pharmacokinetics of
diminazene
(
2) suggest that most of the dose administered
would be eliminated
by the time that a significant quantity of ISMM had
been released.
Further improvement of the devices could also be
realized by incorporating
a higher concentration of anti-inflammatory
product in the coating
to avoid the development of tissue reactions at
the implantation
site.
Although the possibility of development of drug resistance with the use
of SRDs cannot be excluded, preliminary results obtained
by Geerts et
al. (
12) indicate that the rate of development
of resistance
is no faster after administration of an SRD than
after the classical
i.m. injection. By comparing breakthrough
isolates of
T. congolense collected from animals treated with
homidium bromide
i.m. or via an SRD, those investigators could
not detect any loss of
drug sensitivity in the latter isolates
compared to that in the former
isolates. By the mouse test described
by Sones et al. (
20),
the dose which resulted in permanent cure
of 80% of the mice was 2 mg/kg for both isolates. Further research
is necessary, however, in
order to examine this aspect in more
detail.
 |
ACKNOWLEDGMENTS |
The assistance of the technical personnel of the Laboratoire
Central Vétérinaire of Bamako is gratefully acknowledged.
We also thank D. Berkvens for help with the statistical analysis of the
results.
This research project was financially supported by the EU-STD3 program
(contract TS3-CT93-240).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium. Phone: 32-3-2476262. Fax: 32-3-2161431. E-mail: sgeerts{at}itg.be.
 |
REFERENCES |
| 1.
|
Ainanshe, O. A.,
F. W. Jennings, and P. H. Holmes.
1992.
Isolation of drug-resistant strains of Trypanosoma congolense from the lower Shabelle region of southern Somalia.
Trop. Anim. Health Prod.
24:65-73[Medline].
|
| 2.
|
Aliu, Y. O.,
M. Mamman, and A. S. Peregrine.
1993.
Pharmacokinetics of diminazene in female Boran (Bos indicus) cattle.
J. Vet. Pharmacol. Therap.
16:291-300[Medline].
|
| 3.
|
Boyt, W. P.
1971.
Trypanosomiasis control in Rhodesia.
Bull. Off. Int. Epizoot.
76:301-306.
|
| 4.
|
Challier, A., and C. Laveissiere.
1973.
Un nouveau piège pour la capture des glossines (Glos-sina: Diptera, Muscidae), description et essais sur le terrain.
Cah. ORSTOM Ser. Entomol. Med. Parasitol.
11:251-262.
|
| 5.
|
Cox, D. R.
1972.
Regression models and life-tables.
J. R. Statist. Soc. B.
34:187-220.
|
| 6.
|
De Deken, R.,
S. Geerts,
P. Kageruka,
F. Ceulemans,
J. Brandt,
E. Schacht,
C. Pascucci, and C. Lootens.
1989.
Chemoprophylaxis of trypanosomiasis, due to Trypanosoma (Nannomonas) congolense in rabbits using a slow release device containing homidium bromide.
Ann. Soc. Belge Med. Trop.
69:291-296[Medline].
|
| 7.
|
Diall, O.,
Z. Bocoum,
Y. Sanogo, and Z. Yattara.
1986.
Incidence de la trypanosomose bovine au ranch de Madina-Diassa (Mali). Traitement curatif des animaux malades.
Rev. Elev. Med. Vet. Pays Trop.
39:301-305[Medline].
|
| 8.
|
Diall, O.,
O. B. Toure,
B. Diarra, and Y. Sanogo.
1992.
Trypanosomose et traitements trypanocides chez le veau Ndama en milieu fortement infesté de glossines (ranch de Madina-Diassa au Mali).
Rev. Elev. Med. Vet. Pays Trop.
45:155-161[Medline].
|
| 9.
|
Diallo, A.
1985.
Glossina morsitans submorsitans Newstead 1910
In
(Diptera-Glossinidae): son écologie et son rôle dans les trypanosomoses animales en zone de savanne soudano-guinéenne du Mali (ranch de Madina-Diassa). Thèse de doctorat es Sciences Naturelles Faculté des Sciences et Techniques, Aix Marseille III, Marseille, France.
|
| 10.
|
Dolan, R. B.,
P. G. W. Stevenson,
H. Alushala, and G. Okech.
1992.
Failure of chemoprophylaxis against bovine trypanosomiasis in Galana ranch.
Acta Trop.
51:113-121[Medline].
|
| 11.
|
Geerts, S.,
R. De Deken,
P. Kageruka,
K. Lootens, and E. Schacht.
1993.
Evaluation of the efficacy of a slow release device containing homidium bromide in rabbits infected with Trypanosoma congolense.
Vet. Parasitol.
50:15-21[Medline].
|
| 12.
|
Geerts, S.,
P. Kageruka,
R. De Deken,
J. R. A. Brandt,
J. M. Kazadi,
B. Diarra,
M. C. Eisler,
Y. Lemmouchi,
E. Schacht, and P. H. Holmes.
1997.
Prophylactic effects of isometamidium- and ethidium-sustained release devices against Trypanosoma congolense in cattle.
Acta Trop.
65:23-31[Medline].
|
| 13.
|
Kageruka, P.,
H. Kabore,
T. Marcotty,
J. F. Ibouesse,
R. De Deken,
S. Geerts,
Y. Lemmouchi, and E. Schacht.
1996.
Comparative evaluation of the prophylactic effect of slow release devices containing homidium bromide and isometamidium on Trypanosoma congolense in rabbits.
Vet. Parasitol.
63:179-185[Medline].
|
| 14.
|
Murray, M.,
P. K. Murray, and W. McIntyre.
1977.
An improved parasitological technique for the diagnosis of African trypanosomiasis.
Trans. R. Soc. Trop. Med. Hyg.
71:325-326[Medline].
|
| 15.
|
Ogunyemi, O., and A. A. Ilemobade.
1989.
Prophylaxis of African animal trypanosomiasis. A review of some factors that may influence the duration of isometamidium chloride prophylaxis.
Vet. Bull.
59:1-4.
|
| 16.
|
Peregrine, A. S.
1994.
Chemotherapy and delivery systems: haemoparasites.
Vet. Parasitol.
54:223-248[Medline].
|
| 17.
|
Peregrine, A. S.,
S. K. Moloo, and D. D. Whitelaw.
1991.
Differences in sensitivity of Kenyan Trypanosoma vivax populations to the prophylactic and therapeutic actions of isometamidium chloride in Boran cattle.
Trop. Anim. Health Prod.
23:29-38[Medline].
|
| 18.
|
Peregrine, A. S.,
O. Ogunyemi,
D. D. Whitelaw,
P. H. Holmes,
S. K. Moloo,
H. Hirumi,
G. M. Urquhart, and M. Murray.
1988.
Factors influencing the duration of isometamidium chloride (Samorin) prophylaxis against experimental challenge with metacyclic forms of Trypanosoma congolense.
Vet. Parasitol.
28:53-64[Medline].
|
| 19.
|
Pollock, J. N.
1982.
Training manual for tsetse control personnel, vol. 1.
Food and Agriculture Organization, Rome, Italy.
|
| 20.
|
Sones, K. R.,
A. R. Njogu, and P. H. Holmes.
1988.
Assessment of sensitivity of Trypanosoma congolense to isometamidium chloride: a comparison of tests using cattle and mice.
Acta Trop.
45:153-164[Medline].
|
| 21.
|
Stevenson, P.,
K. R. Sones,
M. M. Gisheru, and E. K. Mwangi.
1995.
Comparison of isometamidium chloride and homidium bromide as prophylactic drugs for trypanosomia sis in cattle at Nguruman, Kenya.
Acta Trop.
59:77-84[Medline].
|
Antimicrobial Agents and Chemotherapy, May 1998, p. 1012-1014, Vol. 42, No. 5
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.